ST. PETERSBURG — Following approval from the FDA, genetic testing services like 23andMe and others now have permission to market tests that can test for late-onset Alzheimer's, Parkinson’s and others:
-- Parkinson’s disease, a nervous system disorder impacting movement.
-- Late-onset Alzheimer’s disease, a progressive brain disorder that destroys memory and thinking skills.
-- Celiac disease, a disorder resulting in the inability to digest gluten.
-- Alpha-1 antitrypsin deficiency, a disorder that raises the risk of lung and liver disease.
-- Early-onset primary dystonia, a movement disorder involving involuntary muscle contractions and other uncontrolled movements.
-- Factor XI deficiency, a blood clotting disorder.
-- Gaucher disease type 1, an organ and tissue disorder.
-- Glucose-6-Phosphate Dehydrogenase deficiency, also known as G6PD, a red blood cell condition.
-- Hereditary hemochromatosis, an iron overload disorder.
-- Hereditary thrombophilia, a blood clot disorder.
But would you want to know your chances of developing a disease like Alzheimer’s? 10News is taking a look at what this extra knowledge could mean tonight at 5:30 p.m.